Cloud AWS re:Invent Coverage | Jasmina Desai, Bio-Rad & Siddhartha Shrivastava, Persistent Systems

Clips
News
More from Cloud AWS re:Invent Coverage

Jasmina Desai

Associate Director, R&D Clinical Diagnostics Group

Bio-Rad Laboratories

Siddhartha Shrivastava

Senior Vice President

Persistent Systems

Driving innovation in life sciences: How Bio-Rad and Persistent leverage AWS and AI for transformation

The life sciences and healthcare sectors are undergoing a digital transformation, driven by advancements in cloud infrastructure, life sciences, AI an...

play_circle_outline Leveraging AWS infrastructure, Amazon Q, and generative AI

play_circle_outline Overcoming Challenges in Clinical Diagnostics through Collaboration and Data Privacy with AWS Approach

play_circle_outline Future plans for collaboration with Persistent Systems

Info
Transcript

Jasmina Desai, Bio-Rad & Siddhartha Shrivastava, Persistent Systems

Jasmina Desai

Associate Director, R&D Clinical Diagnostics Group Bio-Rad Laboratories

Siddhartha Shrivastava

Senior Vice President Persistent Systems

Bob Laliberte, principal analyst of theCUBEResearch, discusses collaboration between Bio-Rad, Persistent Systems, and AWS in developing clinical diagnostic applications on AWS infrastructure, Amazon Q, and generative AI. Jasmina addresses data privacy and compliance challenges while Sid outlines Persistent's role in tailoring AWS solutions for Bio-Rad. The partnership has driven success and innovation in the life sciences industry, improving processes and patient outcomes.

explore Keep Exploring

What are some of the unique challenges faced in developing clinical diagnostic applications in the collaboration between Persistent Systems and Bio-Rad Laboratories? add

What were some of the key challenges in developing clinical diagnostic applications on AWS and how did Bio-Rad address these challenges? add

What are the opportunities and goals for the SaaS platform in collaboration with Persistent, leveraging AWS for generative AI offerings, with a focus on delivering technology-enabled business transformation solutions for Bio-Rad in the fields of clinical diagnostics and life sciences? add

bolt Powered by CUBE AI

Jasmina Desai, Bio-Rad & Siddhartha Shrivastava, Persistent Systems

search

Bob Laliberte

>> Hello, I'm Bob Laliberte, principal analyst of theCUBEResearch, and welcome to our Boston Studio for a special CUBE conversation, part of our exclusive CUBE coverage of AWS's annual conference, re:Invent. I'm joined by Jasmina Desai, chief architect and associate director for R&D, clinical diagnostics group, at Bio-Rad, and Sid Cerivastatin, the senior VP for healthcare and life sciences at Persistent Systems. Welcome, Jasmina and Sid.

Jasmina Desai

>> I'm glad to be here as well, thank you.

>> Thank you for having us.

Bob Laliberte

>> Yeah, absolutely. So I think we've got a great discussion lined up today, all about the strategic collaboration between Persistent Systems and Bio-Rad Laboratories. We're going to explore how their partnership is driving innovation, particularly through the development of advanced applications, leveraging AWS infrastructure, Amazon Q, and generative AI. So let's start by discussing one of the key aspects of your collaboration, developing the clinical diagnostic applications. That usually comes with a lot of unique challenges, especially when it comes to data privacy, regulatory compliance, scalability. Jasmina, I was wondering if you could share how Bio-Rad approached these challenges while working on AWS.

Jasmina Desai

>> Indeed. So the life sciences industry is governed by strict regulations, including HIPAA and GDPR, making data privacy and compliance absolutely critical. At the onset of our project, the top priority was to build a secure, scalable environment, capable of managing sensitive customer data without sacrificing performance. AWS, that's our trusted partner, served as the foundation for our cloud infrastructure, while Persistent's expertise and strong partnership were instrumental in developing solutions tailored to our global customer requirements. Their team collaborated with us closely from the design phase to ensure all necessary security protocols were integrated seamlessly, enabling us to scale efficiently without compromising security. Whether it is for protecting our customers for data privacy who trust us with their data, using HIPAA-eligible services for compliance, or ensuring data integrity, this partnership with AWS and Persistent has truly been impactful.

Bob Laliberte

>> Excellent. And Sid, would you like to provide any additional details of the partnership from Persistent's perspective?

>> Yes. So our role was to tailor AWS solutions to meet Bio-Rad's specific needs. We leveraged our domain expertise in life sciences and worked closely with Bio-Rad's team to address compliance and data privacy needs, while ensuring that the applications are scalable and efficient. The collaboration allowed us to co-develop a solution that could handle the scale of Bio-Rad's global operations seamlessly.

Bob Laliberte

>> Excellent, that sounds like a great partnership. Let's dive into the technology side, if we could. Jasmina, can you talk about how Bio-Rad is leveraging Amazon Q and generative AI in the clinical diagnostics business group?

Jasmina Desai

>> Sure. So these technologies have truly been transformative for us. Leveraging cutting-edge AWS infrastructure and services, along with the integration of Amazon Q and generative AI, we have greatly enhanced our R&D capabilities. Generative AI, for instance, chatbots that assist customers in various ways, such as answering product-related questions or providing step-by-step instructions for using features. Looking ahead, it has the potential to support researchers in data analysis, enabling faster data-driven decision-making. This innovation's streamlining numerous processes, allowing our stakeholders to focus their efforts on more complex and strategic tasks.

Bob Laliberte

>> Yeah, that's a great use of technology. And Sid, I'm wondering, from Persistent's perspective, how do you see these technologies fitting into the broader digital transformation goals for clients like Bio-Rad?

>> So generative AI and tools like Amazon Q are key enablers for innovation. By embedding these technologies, we have been able to automate complex tasks, reduce manual efforts, and accelerate decision-making. This is just the beginning. We see even greater potential as we continue to integrate more advanced AI capabilities. Persistent also has its AI orchestrator solution, SASVA, that can force-multiply the impact of AI tools like Amazon Q.

Bob Laliberte

>> Got it, cool. And I wonder if you could then maybe elaborate a little bit more on Persistent Systems' specific contributions to Bio-Rad's digital transformation journey.

>> So we have been partners with Bio-Rad in ideation, design, and development of business solutions for many years now. Persistent comes with deep domain expertise in life sciences. For projects like the one that we are discussing now, we took a consultative approach, ensuring that the solution aligns with Bio-Rad's strategic objectives. We have also leveraged our expertise in legacy product sustenance for Bio-Rad and to support their businesses. With Bio-Rad, we have been able to showcase the potential of our capabilities in cloud, AI, and digital transformation. We believe that this collaboration is a blueprint for how technology can be leveraged to solve complex challenges in life sciences.

Jasmina Desai

>> And I would like to emphasize that Persistent's ability to understand our business requirements and deliver customized solutions has been invaluable. Their extensive expertise in cloud and application development seamlessly complemented our internal capabilities. Together, we have enhanced and built cloud applications using secure software development practices, while adhering to the AWS Well-Architected framework and industry best practices. Whether it started as a simple feature or evolved into a complex feature-rich solution, this collaboration has consistently driven success. For instance, we have developed several innovative quality control data management solutions, and continue to deliver added value to our customers, through our strong partnership with Persistent, and, of course, with AWS.

Bob Laliberte

>> Yeah, it sounds like you're both really benefiting from this relationship and getting a lot out of it. So given all the success that you've had to date, what's next for this partnership? Jasmina, maybe you could share any insights you have into future plans, especially around your partnership with Persistent.

Jasmina Desai

>> We are thrilled about the opportunities that lie ahead. Our SaaS platform is designed to optimize quality control processes, empowering customers to make informed decisions and prioritize patient safety with confidence. As we move forward, we are excited to continue our journey in collaboration with Persistent. AWS remains our primary platform, and we are leveraging its services, particularly generative AI offerings, like AWS Bedrock, Amazon Q, and others, to deliver innovative customer-focused solutions.

>> Jasmina articulated quite well, our primary focus is to always deliver technology-enabled business transformation solutions for Bio-Rad. We want to build scalable, intelligent solutions that continue to deliver value to Bio-Rad and to Bio-Rad's mission of advancing scientific discovery and improving healthcare. We would like to continue to partner with Bio-Rad's clinical diagnostics and life sciences businesses to deliver market-relevant solutions.

Bob Laliberte

>> Excellent, that's great. Well, before we wrap up, I'd like to understand how all the technology and innovation we've just discussed has positively impacted the customers, so wondering if you could share what kind of outcomes that you're seeing as a result of the partnership and the solutions you've created.

Jasmina Desai

>> From Bio-Rad's perspective, the impact is profound, I would say. We are not just improving our internal processes, we are actually setting a new standard for digital solutions in life sciences. By integrating cutting-edge technologies, like generative AI and predictive analytics, we are able to deliver faster, more accurate results, eventually enhancing patient outcomes. This partnership with Persistent and AWS has allowed us to be more agile and responsive in this ever-evolving industry landscape.

>> And from a Persistent standpoint, as strategic partners, our approach has always been to have the end user in mind for our solutions. The end user could be a patient, a healthcare professional, a lab user, and so on and so forth. Even for this solution, it is all about solving business-relevant problems for the clinical diagnostics business, it's about bringing the power of technology to where it can make the most difference in advancing science and improving patient outcomes.

Bob Laliberte

>> Yeah. And that's really what it's all about, right, improving those patient outcomes, delivering better healthcare services, et cetera, so really awesome. Thank you so much for joining us, this has really been a great conversation. It's clear that the partnership between Persistent and Bio-Rad's driving real value and outcomes for your customers. Before we leave, any final thoughts?

Jasmina Desai

>> Absolutely. Together, we are setting a strong foundation for the future, and I'm really excited about what's next.

>> It's been a pleasure sharing our journey. We are committed to this partnership and pushing the boundaries of what technology can achieve in the life sciences space.

Bob Laliberte

>> Excellent. Well, thank you, Jasmina and Sid, for your time, and I want to thank all of you for watching this special CUBE conversation from our Boston studio, part of our exclusive CUBE coverage of AWS's Annual conference, re:Invent. For more information on Persistent's services and solutions, check out their booth at the re:Invent show floor or on their website. And be sure to swing by theCUBE on MediaRow, say hello.